ADMA Biologics Announces Pricing of Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Adma Biologics (ADMA) Prices 1.23M Common Offering for Proceeds of $9.8M
March 13, 2015 9:22 AM EDTAdma Biologics (NASDAQ: ADMA) announced the pricing of its previously announced underwritten public offering of 1,225,000 shares of common stock at a public offering price of $8.00 per share, resulting in gross proceeds of approximately $9,800,000.
The offering is expected to close on March 18, 2015, subject to the... More
